Best Immunotherapy Doctors in India
To access cutting‑edge checkpoint inhibitors, monoclonal antibodies and CAR‑T cell therapies, choosing the best immunotherapy doctors in India is crucial. The country is home to globally recognised medical oncologists who are experienced in delivering advanced treatments using state-of-the-art technologies and evidence-based protocols. They practise in tertiary hospitals that house GMP cell‑labs, PET‑MRIs and high‑precision infusion suites, enabling safe delivery of nivolumab, pembrolizumab, durvalumab and bespoke CAR‑T products. With treatment costs typically 40–60 % lower than in the US and UK, India attracts thousands of international patients each year for advanced cancer immunotherapy care.
How to Select the Best Immunotherapy Doctor in India?
Specialist team
- Medical oncologists – plan and administer checkpoint inhibitors/monoclonal antibodies.
- Haemato‑oncologists – perform CAR‑T and bone‑marrow‑related cellular therapies.
- Radiation oncologists – integrate immunotherapy with SBRT or proton therapy for synergy.
Checklist before deciding
- Review the doctor’s published immunotherapy in India case volume and trial participation.
- Prefer NABH/JCI-accredited centres such as Fortis, Apollo Cancer Centres, Artemis or Breach Candy.
- Ask whether the unit can manage immune‑related adverse events (ICU back‑up, endocrinology, dermatology).
- Check if the hospital runs or can enrol you in clinical immunotherapy trials for newer molecules.
- For overseas patients, confirm availability of medical visa assistance, interpreters and virtual follow‑ups.
Patient Outcomes & Innovations
Checkpoint inhibitors now yield ~45 % two‑year survival in advanced non‑small‑cell lung cancer, while CAR‑T remission rates exceed 60 % in relapsed B‑cell malignancies. Apollo became India’s first private group to launch an indigenously manufactured CAR‑T product, NexCAR19, cutting therapy time and price by nearly 30 %.
FAQs
Q1. Who are the best doctors for immunotherapy in India?
Top doctors for immunotherapy in India at Breach Candy & Reliance Foundation, Fortis, Sir Ganga Ram Hospital, and Artemis Hospitals are widely recognized for their excellent work.
Q2. Which cancers are commonly treated with immunotherapy in India?
Cancers like Lung, melanoma, kidney, bladder, triple‑negative breast and Hodgkin lymphoma; CAR‑T is available for B‑cell leukaemias and lymphomas.
Q3. Which hospitals offer advanced immunotherapy programmes?
Apollo Cancer Centres, Fortis Hospitals, Tata Memorial, Artemis and Sir Ganga Ram run dedicated immuno-oncology units with trial access and have top immunotherapy experts in India.
Q4. Is CAR‑T cell therapy available in India?
Yes—Apollo, Tata Memorial and AIIMS Delhi currently deliver FDA‑grade or indigenous CAR‑T products.
Q5. Are second opinions and tele‑consults offered?
Leading immunotherapy doctors in India provide remote record reviews and virtual consults, allowing you to confirm suitability before travel.
Q6. What is the cost of immunotherapy in India?
Checkpoint inhibitors cost ₹1–2.5 lakh per infusion, while CAR‑T packages range from ₹20–40 lakh—still 50–70 % less than Western centres.
